Dark Genome | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

7,830 results for “Dark Genome”

Haya Therapeutics Secures $65M to Develop Drugs Targeting the 'Dark Genome'

Japanese Consortium Develops AI-Powered Cancer Vaccines Targeting Dark Genome Antigens

HAYA Therapeutics Secures $65 Million Series A to Advance RNA-Guided Medicines Targeting the "Dark Genome"

Kahimmune Therapeutics Secures Exclusive License for Dark Genome Cancer Vaccine Platform

ROME Therapeutics' Landmark Study Reveals Novel LINE-1 Activity Patterns Across Cancer Types

Evaxion Unveils AI-Designed Cancer Vaccine EVX-04 Targeting Acute Myeloid Leukemia

UbiVac's DPV-001 Cancer Vaccine Shows 3x Response Rate Improvement in Head and Neck Cancer Trial

HERVolution Therapeutics Secures $11.7 Million Series A to Advance HERV-Targeted Immunotherapies

Novel ADAR1 Inhibitor Rebecsinib Shows Promise in Halting Cancer Progression Through Space-Based Research

ROME Therapeutics Presents Data on LINE-1 Reverse Transcriptase Inhibitors for Autoimmune Diseases

Page 1 of 227